I agree that this site is using cookies. You can find further informations here.
X
Bekaii-Saab, T.S.
126  results:
Search for persons X
?
1

P1.15-08 Phase 1: IMU-201 (PD1-Vaxx), a B-Cell Immunotherap..:

Richardson, G.E. ; Park, J.J. ; Boyer, M.J....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S123 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Practical considerations in screening for genetic alteratio..:

Bekaii-Saab, T.S. ; Bridgewater, J. ; Normanno, N.
Annals of Oncology.  32 (2021)  9 - p. 1111-1126 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Safety and Effectiveness of Bevacizumab Treatment for Metas..:

Hurwitz, H.I. ; Bekaii-Saab, T.S. ; Bendell, J.C....
Clinical Oncology.  26 (2014)  6 - p. 323-332 , 2014
Link: https://doi.org/10.1016/..
 
?
4

6013 POSTER DISCUSSION Cumulative Exposure to Bevacizumab (..:

Grothev, A. ; Bekaii-Saab, T.S. ; Hurwitz, H....
European Journal of Cancer.  47 (2011)  - p. S395 , 2011
Link: https://doi.org/10.1016/..
 
?
5

323P NALIRIFOX versus nab-paclitaxel and gemcitabine (Gem+N..:

Macarulla Mercade, T. ; Pazo Cid, R.A. ; Womack, M....
Annals of Oncology.  35 (2024)  - p. S135-S136 , 2024
Link: https://doi.org/10.1016/..
 
?
6

HSD106 Metastatic Colorectal Cancer (mCRC) Patients Treated..:

Barzi, A ; Appukkuttan, S ; Hocum, B...
Value in Health.  27 (2024)  6 - p. S239 , 2024
Link: https://doi.org/10.1016/..
 
?
7

293P Durvalumab plus gemcitabine and cisplatin in advanced ..:

Gardini, A. Casadei ; Fornaro, L. ; Lonardi, S....
Annals of Oncology.  35 (2024)  - p. S124 , 2024
Link: https://doi.org/10.1016/..
 
?
8

The management of hepatocellular carcinoma. Current expert ..:

Ducreux, M. ; Abou-Alfa, G.K. ; Bekaii-Saab, T....
ESMO Open.  8 (2023)  3 - p. 101567 , 2023
Link: https://doi.org/10.1016/..
 
?
9

161P A phase Ib study to evaluate IK-007 in combination wit..:

Tolcher, A.W. ; Spigel, D.R. ; Leal, A.D....
Immuno-Oncology and Technology.  16 (2022)  - p. 100273 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Germline Cancer Testing in Unselected Patients with Gastric..:

Uson Jr., P. L. S. ; Kunze, K. L. ; Golafshar, M. A....
Digestive Diseases and Sciences.  67 (2022)  11 - p. 5107-5115 , 2022
Link: https://doi.org/10.1007/..
 
?
11

Association of clinical factors and recent anticancer thera..:

Grivas, P. ; Khaki, A.R. ; Wise-Draper, T.M....
Annals of Oncology.  32 (2021)  6 - p. 787-800 , 2021
Link: https://doi.org/10.1016/..
 
?
12

Impact of Definitive Chemoradiation on Clinical Outcomes in..:

Laughlin, B. ; Jethwa, K.R. ; Sannapaneni, S....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e639 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Clinical Outcome Associated with Neoadjuvant ChemoRT and Or..:

Laughlin, B. ; Petersen, M. ; Yu, N.Y....
International Journal of Radiation Oncology*Biology*Physics.  108 (2020)  3 - p. e598-e599 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Phase 1 Study of Trametinib and Neoadjuvant Chemoradiation ..:

Wuthrick, E.J. ; Williams, T.M. ; Wei, L....
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  2 - p. S107-S108 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Reconsidering the benefit of intermittent versus continuous..:

Sunakawa, Y. ; Bekaii-Saab, T. ; Stintzing, S.
Cancer Treatment Reviews.  45 (2016)  - p. 97-104 , 2016
Link: https://doi.org/10.1016/..
 
1-15